Genitourinary Cancer clinical trials at UC Irvine
1 research study open to eligible people
Showing trials for
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
open to eligible people ages 18 years and up
This is a phase 2a, randomized, double-blinded, placebo-controlled pilot clinical trial determining the impact of riluzole therapy on circulating brain derived neuropathic factor (BDNF) levels of cancer survivors with cancer related cognitive impairment.
Orange, California
Our lead scientists for Genitourinary Cancer research studies include Alexandre Chan.
Last updated: